Immunogenicity, Tolerability, and Safety of BA.1-Adapted BNT162b2 Vaccine in 18- to 55-Year-Olds Previously Vaccinated with BNT162b2 or Who Were COVID-19 Vaccine-Naive
{{output}}
Introduction: Variant-adapted COVID-19 vaccines can induce more robust immune responses against closely matched circulating variants than original vaccines. Metho... ...
